Inhibitory Effects of Myriocin on Non-Enzymatic Glycation of Bovine Serum Albumin
Advanced glycation end products (AGEs) are the compounds produced by non-enzymatic glycation of proteins, which are involved in diabetic-related complications. To investigate the potential anti-glycation activity of Myriocin (Myr), a fungal metabolite of Cordyceps, the effect of Myr on the formation...
Saved in:
Published in | Molecules (Basel, Switzerland) Vol. 27; no. 20; p. 6995 |
---|---|
Main Authors | , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Basel
MDPI AG
01.10.2022
MDPI |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Advanced glycation end products (AGEs) are the compounds produced by non-enzymatic glycation of proteins, which are involved in diabetic-related complications. To investigate the potential anti-glycation activity of Myriocin (Myr), a fungal metabolite of Cordyceps, the effect of Myr on the formation of AGEs resulted from the glycation of bovine serum albumin (BSA) and the interaction between Myr and BSA were studied by multiple spectroscopic techniques and computational simulations. We found that Myr inhibited the formation of AGEs at the end stage of glycation reaction and exhibited strong anti-fibrillation activity. Spectroscopic analysis revealed that Myr quenched the fluorescence of BSA in a static process, with the possible formation of a complex (approximate molar ratio of 1:1). The binding between BSA and Myr mainly depended on van der Waals interaction, hydrophobic interactions and hydrogen bond. The synchronous fluorescence and UV-visible (UV-vis) spectra results indicated that the conformation of BSA altered in the presence of Myr. The fluorescent probe displacement experiments and molecular docking suggested that Myr primarily bound to binding site 1 (subdomain IIA) of BSA. These findings demonstrate that Myr is a potential anti-glycation agent and provide a theoretical basis for the further functional research of Myr in the prevention and treatment of AGEs-related diseases. |
---|---|
AbstractList | Advanced glycation end products (AGEs) are the compounds produced by non-enzymatic glycation of proteins, which are involved in diabetic-related complications. To investigate the potential anti-glycation activity of Myriocin (Myr), a fungal metabolite of Cordyceps, the effect of Myr on the formation of AGEs resulted from the glycation of bovine serum albumin (BSA) and the interaction between Myr and BSA were studied by multiple spectroscopic techniques and computational simulations. We found that Myr inhibited the formation of AGEs at the end stage of glycation reaction and exhibited strong anti-fibrillation activity. Spectroscopic analysis revealed that Myr quenched the fluorescence of BSA in a static process, with the possible formation of a complex (approximate molar ratio of 1:1). The binding between BSA and Myr mainly depended on van der Waals interaction, hydrophobic interactions and hydrogen bond. The synchronous fluorescence and UV-visible (UV-vis) spectra results indicated that the conformation of BSA altered in the presence of Myr. The fluorescent probe displacement experiments and molecular docking suggested that Myr primarily bound to binding site 1 (subdomain IIA) of BSA. These findings demonstrate that Myr is a potential anti-glycation agent and provide a theoretical basis for the further functional research of Myr in the prevention and treatment of AGEs-related diseases. Advanced glycation end products (AGEs) are the compounds produced by non-enzymatic glycation of proteins, which are involved in diabetic-related complications. To investigate the potential anti-glycation activity of Myriocin (Myr), a fungal metabolite of Cordyceps, the effect of Myr on the formation of AGEs resulted from the glycation of bovine serum albumin (BSA) and the interaction between Myr and BSA were studied by multiple spectroscopic techniques and computational simulations. We found that Myr inhibited the formation of AGEs at the end stage of glycation reaction and exhibited strong anti-fibrillation activity. Spectroscopic analysis revealed that Myr quenched the fluorescence of BSA in a static process, with the possible formation of a complex (approximate molar ratio of 1:1). The binding between BSA and Myr mainly depended on van der Waals interaction, hydrophobic interactions and hydrogen bond. The synchronous fluorescence and UV-visible (UV-vis) spectra results indicated that the conformation of BSA altered in the presence of Myr. The fluorescent probe displacement experiments and molecular docking suggested that Myr primarily bound to binding site 1 (subdomain IIA) of BSA. These findings demonstrate that Myr is a potential anti-glycation agent and provide a theoretical basis for the further functional research of Myr in the prevention and treatment of AGEs-related diseases.Advanced glycation end products (AGEs) are the compounds produced by non-enzymatic glycation of proteins, which are involved in diabetic-related complications. To investigate the potential anti-glycation activity of Myriocin (Myr), a fungal metabolite of Cordyceps, the effect of Myr on the formation of AGEs resulted from the glycation of bovine serum albumin (BSA) and the interaction between Myr and BSA were studied by multiple spectroscopic techniques and computational simulations. We found that Myr inhibited the formation of AGEs at the end stage of glycation reaction and exhibited strong anti-fibrillation activity. Spectroscopic analysis revealed that Myr quenched the fluorescence of BSA in a static process, with the possible formation of a complex (approximate molar ratio of 1:1). The binding between BSA and Myr mainly depended on van der Waals interaction, hydrophobic interactions and hydrogen bond. The synchronous fluorescence and UV-visible (UV-vis) spectra results indicated that the conformation of BSA altered in the presence of Myr. The fluorescent probe displacement experiments and molecular docking suggested that Myr primarily bound to binding site 1 (subdomain IIA) of BSA. These findings demonstrate that Myr is a potential anti-glycation agent and provide a theoretical basis for the further functional research of Myr in the prevention and treatment of AGEs-related diseases. Advanced glycation end products (AGEs) are the compounds produced by non-enzymatic glycation of proteins, which are involved in diabetic-related complications. To investigate the potential anti-glycation activity of Myriocin (Myr), a fungal metabolite of Cordyceps , the effect of Myr on the formation of AGEs resulted from the glycation of bovine serum albumin (BSA) and the interaction between Myr and BSA were studied by multiple spectroscopic techniques and computational simulations. We found that Myr inhibited the formation of AGEs at the end stage of glycation reaction and exhibited strong anti-fibrillation activity. Spectroscopic analysis revealed that Myr quenched the fluorescence of BSA in a static process, with the possible formation of a complex (approximate molar ratio of 1:1). The binding between BSA and Myr mainly depended on van der Waals interaction, hydrophobic interactions and hydrogen bond. The synchronous fluorescence and UV-visible (UV- vis ) spectra results indicated that the conformation of BSA altered in the presence of Myr. The fluorescent probe displacement experiments and molecular docking suggested that Myr primarily bound to binding site 1 (subdomain IIA) of BSA. These findings demonstrate that Myr is a potential anti-glycation agent and provide a theoretical basis for the further functional research of Myr in the prevention and treatment of AGEs-related diseases. |
Audience | Academic |
Author | Xu, Junling Dang, Jinye Cai, Jiaxiu Liu, Yang He, Libo Wang, Weiyan Duan, Wei Liu, Ke Li, Jingjing Cheng, Guohua Yu, Meng |
AuthorAffiliation | 2 Department of Central Laboratory, The First People’s Hospital of Huzhou, First Affiliated Hospital of Huzhou University, Huzhou 313000, China 1 Key Laboratory of Bio-Resource and Eco-Environment of Ministry of Education, College of Life Sciences, Sichuan University, Chengdu 610065, China 3 School of Medicine, Deakin University, Geelong, VIC 3216, Australia |
AuthorAffiliation_xml | – name: 3 School of Medicine, Deakin University, Geelong, VIC 3216, Australia – name: 2 Department of Central Laboratory, The First People’s Hospital of Huzhou, First Affiliated Hospital of Huzhou University, Huzhou 313000, China – name: 1 Key Laboratory of Bio-Resource and Eco-Environment of Ministry of Education, College of Life Sciences, Sichuan University, Chengdu 610065, China |
Author_xml | – sequence: 1 givenname: Libo orcidid: 0000-0003-0157-8018 surname: He fullname: He, Libo – sequence: 2 givenname: Yang surname: Liu fullname: Liu, Yang – sequence: 3 givenname: Junling surname: Xu fullname: Xu, Junling – sequence: 4 givenname: Jingjing surname: Li fullname: Li, Jingjing – sequence: 5 givenname: Guohua surname: Cheng fullname: Cheng, Guohua – sequence: 6 givenname: Jiaxiu surname: Cai fullname: Cai, Jiaxiu – sequence: 7 givenname: Jinye surname: Dang fullname: Dang, Jinye – sequence: 8 givenname: Meng orcidid: 0000-0002-0978-7191 surname: Yu fullname: Yu, Meng – sequence: 9 givenname: Weiyan surname: Wang fullname: Wang, Weiyan – sequence: 10 givenname: Wei surname: Duan fullname: Duan, Wei – sequence: 11 givenname: Ke orcidid: 0000-0002-4683-9325 surname: Liu fullname: Liu, Ke |
BookMark | eNp1klFvFCEQxzemJrbVD-DbJr74ci0ssLu8mJzNtb2kaoz6TFh2uHJhocJuk_XTO9er0asaHhiG3__PAHNSHIUYoCheU3LGmCTnQ_RgJg-5aipSSymeFceUV2TBCJdHf8QvipOct4RUlFNxXHxeh1vXuTGmuVxZC2bMZbTlhzm5aFwoYyg_xrBYhR_zoEdnyis_Gwwwj9j7eO8ClF8gTUO59N00uPCyeG61z_DqcT4tvl2uvl5cL24-Xa0vljcLI1gzLnSrdaUtaSUXrWYSV11NOGmBN6zTwLRtoaG9JJZ1daUp44JasFQIZqXh7LRY7337qLfqLrlBp1lF7dRDIqaN0gkr9qA0B6O7hhEpJZe9aCmTtW2oBNnrnln0erf3upu6AXoDYUzaH5ge7gR3qzbxXsmaNIJTNHj7aJDi9wnyqAaXDXivA8QpK_wVKSpCqxbRN0_QbZxSwKfaUa2gAov7TW00XsAFG_FcszNVy4YLJARjSJ39g8LRw-AMdoh1mD8QNHuBSTHnBFYZNz58JwqdV5SoXTupv9oJlfSJ8tfr_F_zE44J0bo |
CitedBy_id | crossref_primary_10_1002_prot_26506 crossref_primary_10_3390_ijms24129881 crossref_primary_10_3390_molecules29184368 crossref_primary_10_1016_j_molstruc_2024_138416 crossref_primary_10_1016_j_fbio_2024_103790 crossref_primary_10_1016_j_saa_2024_124792 crossref_primary_10_1016_j_biopha_2025_117976 crossref_primary_10_1016_j_foodchem_2024_139880 crossref_primary_10_1080_05704928_2025_2477237 crossref_primary_10_1111_1750_3841_17088 crossref_primary_10_1039_D4AN00358F crossref_primary_10_20402_ajbc_2023_0111 crossref_primary_10_1016_j_bbagen_2024_130613 |
Cites_doi | 10.1016/j.compbiolchem.2018.05.006 10.1007/978-1-4939-9752-7_9 10.1021/ct700301q 10.1016/j.cca.2013.07.013 10.1016/j.foodchem.2021.129118 10.1016/j.freeradbiomed.2013.02.005 10.1002/jcp.27058 10.1016/j.foodchem.2016.08.034 10.1016/j.atherosclerosis.2005.12.029 10.1016/j.molstruc.2010.08.042 10.1039/C9NJ01490J 10.2337/db12-1753 10.1016/j.ijbiomac.2017.10.135 10.1016/j.biochi.2010.12.003 10.1016/j.jcp.2012.09.007 10.1016/j.saa.2019.117738 10.1080/07391102.2010.10507354 10.1016/j.jff.2018.06.024 10.1039/C5RA15550A 10.3390/nu14051026 10.1021/acs.jcim.6b00103 10.1039/C5RA27460E 10.1016/j.foodhyd.2019.105455 10.1080/10408398.2015.1023762 10.1159/000491897 10.3390/molecules25235591 10.1016/j.jlumin.2012.05.018 10.1016/j.tifs.2020.06.002 10.1016/j.ijbiomac.2018.10.173 10.1016/j.ijbiomac.2018.06.189 10.1016/j.foodchem.2009.01.042 10.1074/jbc.RA118.006259 10.1016/bs.acc.2015.07.005 10.3390/cells11081312 10.4161/cbt.13.2.18870 10.2337/db11-0085 10.1016/j.foodcont.2022.109038 10.1016/j.phrs.2008.06.005 10.1007/s00894-018-3578-y 10.1016/j.lwt.2020.109253 10.1161/01.CIR.0000148370.60535.22 10.1194/jlr.M800147-JLR200 10.4196/kjpp.2014.18.1.1 10.1177/1087057110379768 10.1038/s41598-019-44926-5 10.1080/10408398.2012.744738 10.1021/ci049714+ 10.1111/liv.12331 10.1371/journal.pone.0126910 10.1152/ajpgi.00395.2013 10.1016/j.molliq.2019.01.144 10.1016/j.saa.2016.06.036 10.1021/jf104336w 10.1007/s10953-014-0200-5 10.1111/cpr.12509 10.1016/j.ijbiomac.2020.04.226 10.1016/j.bcp.2006.12.023 10.1016/j.foodchem.2018.07.148 10.3390/ijms150915994 10.1080/07391102.2016.1213663 10.1021/ja061301x 10.1016/j.molliq.2018.07.122 10.1016/j.ijbiomac.2016.11.035 10.1016/j.foodchem.2018.12.077 10.1080/00387010.2020.1756343 10.1016/j.bbapap.2012.12.001 10.1080/07391102.2020.1771421 10.1016/S0301-4622(03)00153-4 10.1007/978-0-387-46312-4 10.2337/db11-1399 10.14419/ijbas.v4i2.4123 10.18388/abp.2008_3054 10.1016/j.cmet.2007.01.002 10.1093/nar/gkg520 10.1016/j.abb.2003.08.013 10.2337/diaclin.21.4.186 10.1093/abbs/gmx142 10.1016/j.cmet.2014.09.015 10.1016/j.cca.2012.04.025 10.1074/jbc.M412348200 10.1093/glycob/cwu057 10.1016/j.molstruc.2017.09.082 10.1007/s00894-014-2376-4 10.1002/bio.3010 10.1172/jci.insight.82922 10.1007/s11033-020-06084-0 10.1007/s10719-016-9705-z 10.1016/j.jmb.2008.09.073 10.3390/jcm8071008 10.2174/1570161115666170327162639 |
ContentType | Journal Article |
Copyright | COPYRIGHT 2022 MDPI AG 2022 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. 2022 by the authors. 2022 |
Copyright_xml | – notice: COPYRIGHT 2022 MDPI AG – notice: 2022 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. – notice: 2022 by the authors. 2022 |
DBID | AAYXX CITATION 3V. 7X7 7XB 88E 8FI 8FJ 8FK ABUWG AFKRA AZQEC BENPR CCPQU DWQXO FYUFA GHDGH K9. M0S M1P PHGZM PHGZT PIMPY PJZUB PKEHL PPXIY PQEST PQQKQ PQUKI PRINS 7X8 5PM DOA |
DOI | 10.3390/molecules27206995 |
DatabaseName | CrossRef ProQuest Central (Corporate) ProQuest Health & Medical Collection (NC LIVE) ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central UK/Ireland ProQuest Central Essentials ProQuest Central (NC Live) ProQuest One Community College ProQuest Central Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Health & Medical Complete (Alumni) ProQuest Health & Medical Collection PML(ProQuest Medical Library) ProQuest Central Premium ProQuest One Academic Publicly Available Content Database ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China MEDLINE - Academic PubMed Central (Full Participant titles) DOAJ Directory of Open Access Journals |
DatabaseTitle | CrossRef Publicly Available Content Database ProQuest One Academic Middle East (New) ProQuest Central Essentials ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest One Health & Nursing ProQuest Central China ProQuest Central ProQuest Health & Medical Research Collection Health Research Premium Collection Health and Medicine Complete (Alumni Edition) ProQuest Central Korea Health & Medical Research Collection ProQuest Central (New) ProQuest Medical Library (Alumni) ProQuest One Academic Eastern Edition ProQuest Hospital Collection Health Research Premium Collection (Alumni) ProQuest Hospital Collection (Alumni) ProQuest Health & Medical Complete ProQuest Medical Library ProQuest One Academic UKI Edition ProQuest One Academic ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic |
DatabaseTitleList | Publicly Available Content Database CrossRef MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: BENPR name: ProQuest Central url: https://www.proquest.com/central sourceTypes: Aggregation Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Chemistry |
EISSN | 1420-3049 |
ExternalDocumentID | oai_doaj_org_article_a4ecab73099949d581396f719e9dad3f PMC9607541 A745963533 10_3390_molecules27206995 |
GeographicLocations | United States Maryland China |
GeographicLocations_xml | – name: China – name: Maryland – name: United States |
GrantInformation_xml | – fundername: Nature Science Foundation of Sichuan, China grantid: 2022NSFSC0106 |
GroupedDBID | --- 0R~ 123 2WC 53G 5VS 7X7 88E 8FE 8FG 8FH 8FI 8FJ A8Z AADQD AAFWJ AAHBH AAYXX ABDBF ABUWG ACGFO ACIWK ACPRK ACUHS AEGXH AENEX AFKRA AFPKN AFRAH AFZYC AIAGR ALIPV ALMA_UNASSIGNED_HOLDINGS BENPR BPHCQ BVXVI CCPQU CITATION CS3 D1I DIK DU5 E3Z EBD EMOBN ESX FYUFA GROUPED_DOAJ GX1 HH5 HMCUK HYE HZ~ I09 IAO IHR ITC KQ8 LK8 M1P MODMG O-U O9- OK1 P2P PHGZM PHGZT PIMPY PQQKQ PROAC PSQYO RPM SV3 TR2 TUS UKHRP ~8M PMFND 3V. 7XB 8FK AZQEC DWQXO K9. PJZUB PKEHL PPXIY PQEST PQUKI PRINS 7X8 5PM PUEGO |
ID | FETCH-LOGICAL-c537t-a8aa2af089458a39aa2b60408e473bae3af8e71d90f3b62a13451fef1553f9c43 |
IEDL.DBID | 7X7 |
ISSN | 1420-3049 |
IngestDate | Wed Aug 27 01:19:01 EDT 2025 Thu Aug 21 18:38:45 EDT 2025 Thu Jul 10 16:51:52 EDT 2025 Fri Jul 25 09:36:19 EDT 2025 Thu May 08 04:13:25 EDT 2025 Tue Jun 10 20:52:59 EDT 2025 Tue Jul 01 01:21:30 EDT 2025 Thu Apr 24 22:50:34 EDT 2025 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 20 |
Language | English |
License | https://creativecommons.org/licenses/by/4.0 Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c537t-a8aa2af089458a39aa2b60408e473bae3af8e71d90f3b62a13451fef1553f9c43 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
ORCID | 0000-0003-0157-8018 0000-0002-0978-7191 0000-0002-4683-9325 |
OpenAccessLink | https://www.proquest.com/docview/2728515396?pq-origsite=%requestingapplication% |
PQID | 2728515396 |
PQPubID | 2032355 |
ParticipantIDs | doaj_primary_oai_doaj_org_article_a4ecab73099949d581396f719e9dad3f pubmedcentral_primary_oai_pubmedcentral_nih_gov_9607541 proquest_miscellaneous_2729520128 proquest_journals_2728515396 gale_infotracmisc_A745963533 gale_infotracacademiconefile_A745963533 crossref_citationtrail_10_3390_molecules27206995 crossref_primary_10_3390_molecules27206995 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2022-10-01 |
PublicationDateYYYYMMDD | 2022-10-01 |
PublicationDate_xml | – month: 10 year: 2022 text: 2022-10-01 day: 01 |
PublicationDecade | 2020 |
PublicationPlace | Basel |
PublicationPlace_xml | – name: Basel |
PublicationTitle | Molecules (Basel, Switzerland) |
PublicationYear | 2022 |
Publisher | MDPI AG MDPI |
Publisher_xml | – name: MDPI AG – name: MDPI |
References | (ref_14) 2010; 15 Rabbani (ref_51) 2016; 33 Xi (ref_91) 2016; 169 Benvidi (ref_64) 2018; 107 Wang (ref_92) 2018; 1152 Davis (ref_9) 2016; 56 Khan (ref_55) 2018; 269 Correnti (ref_32) 2014; 306 Park (ref_28) 2008; 58 Xue (ref_21) 2022; 138 Raichur (ref_31) 2014; 20 Xu (ref_6) 2018; 48 Park (ref_35) 2008; 49 Awasthi (ref_65) 2019; 122 Ahmad (ref_77) 2017; 15 Caruso (ref_59) 2020; 228 Oliveira (ref_39) 2013; 1834 Rabbani (ref_7) 2011; 60 Awasthi (ref_82) 2016; 6 Irwin (ref_84) 2005; 45 Zhao (ref_61) 2018; 75 Asgharzadeh (ref_87) 2019; 280 Hojjati (ref_25) 2005; 280 Glaros (ref_27) 2007; 73 Awasthi (ref_72) 2015; 5 Kurek (ref_29) 2014; 34 Olsson (ref_54) 2008; 384 Zhang (ref_34) 2012; 61 Ji (ref_36) 2017; 2 Xi (ref_62) 2019; 9 Zabielski (ref_38) 2019; 234 Militello (ref_15) 2003; 105 Li (ref_90) 2014; 15 Zhang (ref_67) 2020; 39 Wang (ref_68) 2014; 20 Vermaas (ref_93) 2016; 56 Lee (ref_23) 2012; 13 Park (ref_24) 2004; 110 Xu (ref_47) 2019; 281 Zheng (ref_75) 2012; 413 ref_78 Lv (ref_5) 2016; 14 Boulanger (ref_42) 2006; 2 Khan (ref_80) 2020; 159 Wang (ref_89) 2018; 24 ref_30 Gao (ref_56) 2010; 983 Jisha (ref_60) 2006; 128 Anguizola (ref_73) 2013; 425 Shen (ref_20) 2017; 216 Zeng (ref_70) 2019; 271 Park (ref_26) 2006; 189 Zhang (ref_57) 2020; 53 (ref_13) 2008; 55 Peppa (ref_3) 2003; 21 Holland (ref_37) 2007; 5 Lv (ref_52) 2017; 57 Rondeau (ref_12) 2011; 93 Li (ref_66) 2018; 51 Yue (ref_46) 2016; 31 Hess (ref_88) 2008; 4 Ahmad (ref_40) 2014; 24 Lu (ref_69) 2018; 50 ref_81 Zhang (ref_50) 2020; 101 Zhu (ref_53) 2014; 43 Gordon (ref_74) 2013; 62 Makowski (ref_16) 2015; Volume 72 Zhao (ref_44) 2018; 118 Zhang (ref_79) 2021; 349 ref_45 Ding (ref_71) 2020; 125 Rauf (ref_85) 2015; 4 Wang (ref_49) 2013; 235 Shobana (ref_10) 2009; 115 Anwar (ref_17) 2021; 48 Hanada (ref_22) 2003; 1632 Thornalley (ref_41) 2003; 419 Prasanna (ref_43) 2017; 95 Tripathy (ref_58) 2012; 132 Michelis (ref_76) 2013; 60 ref_1 Pintro (ref_83) 2019; 2053 ref_2 Chen (ref_33) 2019; 294 Shi (ref_48) 2017; 35 ref_8 Zhou (ref_18) 2020; 103 Singh (ref_4) 2014; 18 Liu (ref_19) 2018; 48 Nasiri (ref_63) 2010; 28 Schwede (ref_86) 2003; 31 Buckow (ref_11) 2011; 59 |
References_xml | – volume: 75 start-page: 120 year: 2018 ident: ref_61 article-title: In silico structure prediction and inhibition mechanism studies of AtHDA14 as revealed by homology modeling, docking, molecular dynamics simulation publication-title: Comput. Biol. Chem. doi: 10.1016/j.compbiolchem.2018.05.006 – volume: 2053 start-page: 125 year: 2019 ident: ref_83 article-title: Docking with AutoDock4 publication-title: Methods Mol. Biol. doi: 10.1007/978-1-4939-9752-7_9 – volume: 4 start-page: 435 year: 2008 ident: ref_88 article-title: GROMACS 4: Algorithms for Highly Efficient, Load-Balanced, and Scalable Molecular Simulation publication-title: J. Chem. Theory Comput. doi: 10.1021/ct700301q – volume: 425 start-page: 64 year: 2013 ident: ref_73 article-title: Review: Glycation of human serum albumin publication-title: Clin. Chim. Acta doi: 10.1016/j.cca.2013.07.013 – volume: 349 start-page: 129118 year: 2021 ident: ref_79 article-title: Protective effects of three structurally similar polyphenolic compounds against oxidative damage and their binding properties to human serum albumin publication-title: Food Chem. doi: 10.1016/j.foodchem.2021.129118 – volume: 60 start-page: 49 year: 2013 ident: ref_76 article-title: Albumin oxidation leads to neutrophil activation in vitro and inaccurate measurement of serum albumin in patients with diabetic nephropathy publication-title: Free Radic. Biol. Med. doi: 10.1016/j.freeradbiomed.2013.02.005 – volume: 234 start-page: 1851 year: 2019 ident: ref_38 article-title: The effect of high-fat diet and inhibition of ceramide production on insulin action in liver publication-title: J. Cell. Physiol. doi: 10.1002/jcp.27058 – volume: 216 start-page: 153 year: 2017 ident: ref_20 article-title: Ability of resveratrol to inhibit advanced glycation end product formation and carbohydrate-hydrolyzing enzyme activity, and to conjugate methylglyoxal publication-title: Food Chem. doi: 10.1016/j.foodchem.2016.08.034 – volume: 189 start-page: 264 year: 2006 ident: ref_26 article-title: Modulation of lipoprotein metabolism by inhibition of sphingomyelin synthesis in ApoE knockout mice publication-title: Atherosclerosis doi: 10.1016/j.atherosclerosis.2005.12.029 – volume: 983 start-page: 133 year: 2010 ident: ref_56 article-title: Study of interaction between syringin and human serum albumin by multi-spectroscopic method and atomic force microscopy publication-title: J. Mol. Struct. doi: 10.1016/j.molstruc.2010.08.042 – ident: ref_81 doi: 10.1039/C9NJ01490J – volume: 62 start-page: 2958 year: 2013 ident: ref_74 article-title: The Effects of Type 2 Diabetes on Lipoprotein Composition and Arterial Stiffness in Male Youth publication-title: Diabetes doi: 10.2337/db12-1753 – volume: 107 start-page: 2465 year: 2018 ident: ref_64 article-title: Monitoring the protective ability of thymoquinone mixture with p-cymene against bovine serum albumin (BSA) glycation: MCR-ALS analysis based on combined spectroscopic and electrochemical methods publication-title: Int. J. Biol. Macromol. doi: 10.1016/j.ijbiomac.2017.10.135 – volume: 93 start-page: 645 year: 2011 ident: ref_12 article-title: The glycation of albumin: Structural and functional impacts publication-title: Biochimie doi: 10.1016/j.biochi.2010.12.003 – volume: 235 start-page: 1 year: 2013 ident: ref_49 article-title: Forward and adjoint sensitivity computation of chaotic dynamical systems publication-title: J. Comput. Phys. doi: 10.1016/j.jcp.2012.09.007 – volume: 228 start-page: 117738 year: 2020 ident: ref_59 article-title: Fluorescence spectroscopic and dynamics simulation studies on isoorientin binding with human serum albumin publication-title: Spectrochim. Acta Part A Mol. Biomol. Spectrosc. doi: 10.1016/j.saa.2019.117738 – volume: 28 start-page: 211 year: 2010 ident: ref_63 article-title: A Theoretical Elucidation of Glucose Interaction with HSA’s Domains publication-title: J. Biomol. Struct. Dyn. doi: 10.1080/07391102.2010.10507354 – volume: 48 start-page: 19 year: 2018 ident: ref_19 article-title: Ferulic acid inhibits advanced glycation end products (AGEs) formation and mitigates the AGEs-induced inflammatory response in HUVEC cells publication-title: J. Funct. Foods doi: 10.1016/j.jff.2018.06.024 – volume: 5 start-page: 87660 year: 2015 ident: ref_72 article-title: Silybin, a flavonolignan from milk thistle seeds, restrains the early and advanced glycation end product modification of albumin publication-title: RSC Adv. doi: 10.1039/C5RA15550A – ident: ref_78 doi: 10.3390/nu14051026 – volume: 56 start-page: 1112 year: 2016 ident: ref_93 article-title: TopoGromacs: Automated Topology Conversion from CHARMM to GROMACS within VMD publication-title: J. Chem. Inf. Model. doi: 10.1021/acs.jcim.6b00103 – volume: 6 start-page: 24557 year: 2016 ident: ref_82 article-title: Carbonyl scavenging and chemical chaperon like function of essential amino acids attenuates non-enzymatic glycation of albumin publication-title: RSC Adv. doi: 10.1039/C5RA27460E – volume: 101 start-page: 105455 year: 2020 ident: ref_50 article-title: Molecular dynamics simulation exploration of the interaction between curcumin and myosin combined with the results of spectroscopy techniques publication-title: Food Hydrocoll. doi: 10.1016/j.foodhyd.2019.105455 – volume: 57 start-page: 1718 year: 2017 ident: ref_52 article-title: Interactions between plant proteins/enzymes and other food components, and their effects on food quality publication-title: Crit. Rev. Food Sci. Nutr. doi: 10.1080/10408398.2015.1023762 – volume: 1632 start-page: 16 year: 2003 ident: ref_22 article-title: Serine palmitoyltransferase, a key enzyme of sphingolipid metabolism publication-title: Biochim. Et Biophys. Acta (BBA)-Mol. Cell Biol. Lipids – volume: 48 start-page: 705 year: 2018 ident: ref_6 article-title: Involvement of Advanced Glycation End Products in the Pathogenesis of Diabetic Retinopathy publication-title: Cell. Physiol. Biochem. Int. J. Exp. Cell. Physiol. Biochem. Pharmacol. doi: 10.1159/000491897 – ident: ref_2 doi: 10.3390/molecules25235591 – volume: 132 start-page: 2943 year: 2012 ident: ref_58 article-title: An alternate mode of binding of the polyphenol quercetin with serum albumins when complexed with Cu(II) publication-title: J. Lumin. doi: 10.1016/j.jlumin.2012.05.018 – volume: 103 start-page: 333 year: 2020 ident: ref_18 article-title: The multifunctional roles of flavonoids against the formation of advanced glycation end products (AGEs) and AGEs-induced harmful effects publication-title: Trends Food Sci. Technol. doi: 10.1016/j.tifs.2020.06.002 – volume: 122 start-page: 479 year: 2019 ident: ref_65 article-title: Nordihydroguaiaretic acid prevents glycation induced structural alterations and aggregation of albumin publication-title: Int. J. Biol. Macromol. doi: 10.1016/j.ijbiomac.2018.10.173 – volume: 118 start-page: 1136 year: 2018 ident: ref_44 article-title: Study on interaction between human salivary α-amylase and sorghum procyanidin tetramer: Binding characteristics and structural analysis publication-title: Int. J. Biol. Macromol. doi: 10.1016/j.ijbiomac.2018.06.189 – volume: 115 start-page: 1268 year: 2009 ident: ref_10 article-title: Composition and enzyme inhibitory properties of finger millet (Eleusine coracana L.) seed coat phenolics: Mode of inhibition of α-glucosidase and pancreatic amylase publication-title: Food Chem. doi: 10.1016/j.foodchem.2009.01.042 – volume: 294 start-page: 9213 year: 2019 ident: ref_33 article-title: An ANGPTL4–ceramide–protein kinase Cζ axis mediates chronic glucocorticoid exposure–induced hepatic steatosis and hypertriglyceridemia in mice publication-title: J. Biol. Chem. doi: 10.1074/jbc.RA118.006259 – volume: Volume 72 start-page: 205 year: 2015 ident: ref_16 article-title: Chapter Five—Glycated Serum Albumin and AGE Receptors publication-title: Advances in Clinical Chemistry doi: 10.1016/bs.acc.2015.07.005 – ident: ref_1 doi: 10.3390/cells11081312 – volume: 13 start-page: 92 year: 2012 ident: ref_23 article-title: Myriocin, a serine palmitoyltransferase inhibitor, suppresses tumor growth in a murine melanoma model by inhibiting de novo sphingolipid synthesis publication-title: Cancer Biol. doi: 10.4161/cbt.13.2.18870 – volume: 60 start-page: 1973 year: 2011 ident: ref_7 article-title: Glycation of LDL by Methylglyoxal Increases Arterial Atherogenicity: A Possible Contributor to Increased Risk of Cardiovascular Disease in Diabetes publication-title: Diabetes doi: 10.2337/db11-0085 – volume: 138 start-page: 109038 year: 2022 ident: ref_21 article-title: Ginger and curcumin can inhibit heterocyclic amines and advanced glycation end products in roast beef patties by quenching free radicals as revealed by electron paramagnetic resonance publication-title: Food Control doi: 10.1016/j.foodcont.2022.109038 – volume: 58 start-page: 45 year: 2008 ident: ref_28 article-title: Serine palmitoyltransferase inhibitor myriocin induces the regression of atherosclerotic plaques in hyperlipidemic ApoE-deficient mice publication-title: Pharm. Res doi: 10.1016/j.phrs.2008.06.005 – volume: 24 start-page: 57 year: 2018 ident: ref_89 article-title: In silico identification of small molecules as novel LXR agonists for the treatment of cardiovascular disease and cancer publication-title: J. Mol. Model. doi: 10.1007/s00894-018-3578-y – volume: 125 start-page: 109253 year: 2020 ident: ref_71 article-title: The inhibition of oleanolic acid on protein non-enzymatic glycation publication-title: LWT doi: 10.1016/j.lwt.2020.109253 – volume: 110 start-page: 3465 year: 2004 ident: ref_24 article-title: Inhibition of sphingomyelin synthesis reduces atherogenesis in apolipoprotein E-knockout mice publication-title: Circulation doi: 10.1161/01.CIR.0000148370.60535.22 – volume: 49 start-page: 2101 year: 2008 ident: ref_35 article-title: Ceramide is a cardiotoxin in lipotoxic cardiomyopathy publication-title: J. Lipid Res. doi: 10.1194/jlr.M800147-JLR200 – volume: 18 start-page: 1 year: 2014 ident: ref_4 article-title: Advanced Glycation End Products and Diabetic Complications publication-title: Korean J. Physiol. Pharmacol. doi: 10.4196/kjpp.2014.18.1.1 – volume: 14 start-page: 844 year: 2016 ident: ref_5 article-title: Food-advanced glycation end products aggravate the diabetic vascular complications via modulating the AGEs/RAGE pathway publication-title: Chin. J. Nat. Med. – volume: 15 start-page: 1281 year: 2010 ident: ref_14 article-title: Thermally Denatured BSA, a Surrogate Additive to Replace BSA in Buffers for High-Throughput Screening publication-title: SLAS Discov. doi: 10.1177/1087057110379768 – volume: 2 start-page: S8 year: 2006 ident: ref_42 article-title: Glycation, glycoxidation and diabetes mellitus publication-title: Nephrol. Ther. – volume: 9 start-page: 8413 year: 2019 ident: ref_62 article-title: Insight into the structural stability of wild-type and histidine mutants in Pin1 by experimental and computational methods publication-title: Sci. Rep. doi: 10.1038/s41598-019-44926-5 – volume: 56 start-page: 989 year: 2016 ident: ref_9 article-title: Advanced Glycation End Products, Inflammation, and Chronic Metabolic Diseases: Links in a Chain? publication-title: Crit. Rev. Food Sci. Nutr. doi: 10.1080/10408398.2012.744738 – volume: 45 start-page: 177 year: 2005 ident: ref_84 article-title: ZINC—A Free Database of Commercially Available Compounds for Virtual Screening publication-title: J. Chem. Inf. Model. doi: 10.1021/ci049714+ – volume: 34 start-page: 1074 year: 2014 ident: ref_29 article-title: Inhibition of ceramide de novo synthesis reduces liver lipid accumulation in rats with nonalcoholic fatty liver disease publication-title: Liver Int. doi: 10.1111/liv.12331 – ident: ref_30 doi: 10.1371/journal.pone.0126910 – volume: 306 start-page: G959 year: 2014 ident: ref_32 article-title: Pharmacologic ceramide reduction alleviates alcohol-induced steatosis and hepatomegaly in adiponectin knockout mice publication-title: Am. J. Physiol. Gastrointest. Liver Physiol. doi: 10.1152/ajpgi.00395.2013 – volume: 280 start-page: 79 year: 2019 ident: ref_87 article-title: Effect of free L-cysteine on the structure and function of α-chymotrypsin publication-title: J. Mol. Liq. doi: 10.1016/j.molliq.2019.01.144 – volume: 169 start-page: 134 year: 2016 ident: ref_91 article-title: Interaction between Pin1 and its natural product inhibitor epigallocatechin-3-gallate by spectroscopy and molecular dynamics simulations publication-title: Spectrochim. Acta Part A Mol. Biomol. Spectrosc. doi: 10.1016/j.saa.2016.06.036 – volume: 59 start-page: 3915 year: 2011 ident: ref_11 article-title: Conjugation of Bovine Serum Albumin and Glucose under Combined High Pressure and Heat publication-title: J. Agric. Food Chem. doi: 10.1021/jf104336w – volume: 43 start-page: 1232 year: 2014 ident: ref_53 article-title: Interaction Between Ginkgolic Acid and Human Serum Albumin by Spectroscopy and Molecular Modeling Methods publication-title: J. Solut. Chem. doi: 10.1007/s10953-014-0200-5 – volume: 51 start-page: e12509 year: 2018 ident: ref_66 article-title: Computer-aided identification of a novel pyruvate kinase M2 activator compound publication-title: Cell Prolif. doi: 10.1111/cpr.12509 – volume: 159 start-page: 87 year: 2020 ident: ref_80 article-title: Mechanistic inhibition of non-enzymatic glycation and aldose reductase activity by naringenin: Binding, enzyme kinetics and molecular docking analysis publication-title: Int. J. Biol. Macromol. doi: 10.1016/j.ijbiomac.2020.04.226 – volume: 73 start-page: 1340 year: 2007 ident: ref_27 article-title: Inhibition of atherosclerosis by the serine palmitoyl transferase inhibitor myriocin is associated with reduced plasma glycosphingolipid concentration publication-title: Biochem Pharm. doi: 10.1016/j.bcp.2006.12.023 – volume: 271 start-page: 70 year: 2019 ident: ref_70 article-title: Galangin inhibits α-glucosidase activity and formation of non-enzymatic glycation products publication-title: Food Chem. doi: 10.1016/j.foodchem.2018.07.148 – volume: 15 start-page: 15994 year: 2014 ident: ref_90 article-title: In Silico Discovery of Potential VEGFR-2 Inhibitors from Natural Derivatives for Anti-Angiogenesis Therapy publication-title: Int. J. Mol. Sci. doi: 10.3390/ijms150915994 – volume: 35 start-page: 2211 year: 2017 ident: ref_48 article-title: In vitro study on binding interaction of quinapril with bovine serum albumin (BSA) using multi-spectroscopic and molecular docking methods publication-title: J. Biomol. Struct. Dyn. doi: 10.1080/07391102.2016.1213663 – volume: 128 start-page: 6024 year: 2006 ident: ref_60 article-title: Site–Selective Binding and Dual Mode Recognition of Serum Albumin by a Squaraine Dye publication-title: J. Am. Chem. Soc. doi: 10.1021/ja061301x – volume: 269 start-page: 511 year: 2018 ident: ref_55 article-title: Molecular insight into binding behavior of polyphenol (rutin) with beta lactoglobulin: Spectroscopic, molecular docking and MD simulation studies publication-title: J. Mol. Liq. doi: 10.1016/j.molliq.2018.07.122 – volume: 95 start-page: 121 year: 2017 ident: ref_43 article-title: Linolenic acid prevents early and advanced glycation end-products (AGEs) modification of albumin publication-title: Int. J. Biol. Macromol. doi: 10.1016/j.ijbiomac.2016.11.035 – volume: 281 start-page: 28 year: 2019 ident: ref_47 article-title: Characterization of binding interactions of anthraquinones and bovine β-lactoglobulin publication-title: Food Chem. doi: 10.1016/j.foodchem.2018.12.077 – volume: 53 start-page: 360 year: 2020 ident: ref_57 article-title: Mechanism of the interaction between benthiavalicarb-isopropyl and human serum albumin publication-title: Spectrosc. Lett. doi: 10.1080/00387010.2020.1756343 – volume: 1834 start-page: 1010 year: 2013 ident: ref_39 article-title: Insights into the molecular mechanism of protein native-like aggregation upon glycation publication-title: Biochim. Et Biophys. Acta (BBA)-Proteins Proteom. doi: 10.1016/j.bbapap.2012.12.001 – volume: 39 start-page: 3721 year: 2020 ident: ref_67 article-title: Identification of novel potential PI3Kα inhibitors for cancer therapy publication-title: J. Biomol. Struct. Dyn. doi: 10.1080/07391102.2020.1771421 – volume: 105 start-page: 133 year: 2003 ident: ref_15 article-title: Conformational changes involved in thermal aggregation processes of bovine serum albumin publication-title: Biophys. Chem. doi: 10.1016/S0301-4622(03)00153-4 – ident: ref_45 doi: 10.1007/978-0-387-46312-4 – volume: 61 start-page: 1848 year: 2012 ident: ref_34 article-title: Ceramide Mediates Vascular Dysfunction in Diet-Induced Obesity by PP2A-Mediated Dephosphorylation of the eNOS-Akt Complex publication-title: Diabetes doi: 10.2337/db11-1399 – volume: 4 start-page: 168 year: 2015 ident: ref_85 article-title: Ligand docking and binding site analysis with pymol and autodock/vina publication-title: Int. J. Basic Appl. Sci. doi: 10.14419/ijbas.v4i2.4123 – volume: 55 start-page: 491 year: 2008 ident: ref_13 article-title: Characterization of bovine serum albumin glycated with glucose, galactose and lactose publication-title: Acta Biochim. Pol. doi: 10.18388/abp.2008_3054 – volume: 5 start-page: 167 year: 2007 ident: ref_37 article-title: Inhibition of ceramide synthesis ameliorates glucocorticoid-, saturated-fat-, and obesity-induced insulin resistance publication-title: Cell Metab. doi: 10.1016/j.cmet.2007.01.002 – volume: 31 start-page: 3381 year: 2003 ident: ref_86 article-title: SWISS-MODEL: An automated protein homology-modeling server publication-title: Nucleic Acids Res. doi: 10.1093/nar/gkg520 – volume: 419 start-page: 31 year: 2003 ident: ref_41 article-title: Use of aminoguanidine (Pimagedine) to prevent the formation of advanced glycation endproducts publication-title: Arch. Biochem. Biophys. doi: 10.1016/j.abb.2003.08.013 – volume: 21 start-page: 186 year: 2003 ident: ref_3 article-title: Glucose, Advanced Glycation End Products, and Diabetes Complications: What Is New and What Works publication-title: Clin. Diabetes doi: 10.2337/diaclin.21.4.186 – volume: 50 start-page: 456 year: 2018 ident: ref_69 article-title: Identification of two potential glycogen synthase kinase 3β inhibitors for the treatment of osteosarcoma publication-title: Acta Biochim. Et Biophys. Sin. doi: 10.1093/abbs/gmx142 – volume: 20 start-page: 687 year: 2014 ident: ref_31 article-title: CerS2 Haploinsufficiency Inhibits β-Oxidation and Confers Susceptibility to Diet-Induced Steatohepatitis and Insulin Resistance publication-title: Cell Metab. doi: 10.1016/j.cmet.2014.09.015 – volume: 413 start-page: 1555 year: 2012 ident: ref_75 article-title: Glycated albumin in diabetic patients with chronic kidney disease publication-title: Clin. Chim. Acta doi: 10.1016/j.cca.2012.04.025 – volume: 280 start-page: 10284 year: 2005 ident: ref_25 article-title: Effect of myriocin on plasma sphingolipid metabolism and atherosclerosis in apoE-deficient mice publication-title: J. Biol. Chem. doi: 10.1074/jbc.M412348200 – volume: 24 start-page: 979 year: 2014 ident: ref_40 article-title: Glycoxidation of Biological Macromolecules: A Critical Approach to Halt the Menace of Glycation publication-title: Glycobiology doi: 10.1093/glycob/cwu057 – volume: 1152 start-page: 177 year: 2018 ident: ref_92 article-title: The acidic pH-induced structural changes in apo-CP43 by spectral methodologies and molecular dynamics simulations publication-title: J. Mol. Struct. doi: 10.1016/j.molstruc.2017.09.082 – volume: 20 start-page: 2376 year: 2014 ident: ref_68 article-title: Role of pH in structural changes for Pin1 protein: An insight from molecular dynamics study publication-title: J. Mol. Model. doi: 10.1007/s00894-014-2376-4 – volume: 31 start-page: 671 year: 2016 ident: ref_46 article-title: Interaction of human serum albumin with novel imidazole derivatives studied by spectroscopy and molecular docking publication-title: Luminescence doi: 10.1002/bio.3010 – volume: 2 start-page: e82922 year: 2017 ident: ref_36 article-title: Increased de novo ceramide synthesis and accumulation in failing myocardium publication-title: JCI Insight doi: 10.1172/jci.insight.82922 – volume: 48 start-page: 787 year: 2021 ident: ref_17 article-title: A review on mechanism of inhibition of advanced glycation end products formation by plant derived polyphenolic compounds publication-title: Mol. Biol. Rep. doi: 10.1007/s11033-020-06084-0 – volume: 33 start-page: 513 year: 2016 ident: ref_51 article-title: Dicarbonyls and glyoxalase in disease mechanisms and clinical therapeutics publication-title: Glycoconj. J. doi: 10.1007/s10719-016-9705-z – volume: 384 start-page: 1002 year: 2008 ident: ref_54 article-title: The Thermodynamics of Protein–Ligand Interaction and Solvation: Insights for Ligand Design publication-title: J. Mol. Biol. doi: 10.1016/j.jmb.2008.09.073 – ident: ref_8 doi: 10.3390/jcm8071008 – volume: 15 start-page: 352 year: 2017 ident: ref_77 article-title: A Glycation Angle to Look into the Diabetic Vasculopathy: Cause and Cure publication-title: Curr. Vasc. Pharmacol. doi: 10.2174/1570161115666170327162639 |
SSID | ssj0021415 |
Score | 2.4223707 |
Snippet | Advanced glycation end products (AGEs) are the compounds produced by non-enzymatic glycation of proteins, which are involved in diabetic-related complications.... |
SourceID | doaj pubmedcentral proquest gale crossref |
SourceType | Open Website Open Access Repository Aggregation Database Enrichment Source Index Database |
StartPage | 6995 |
SubjectTerms | Albumin Alzheimer's disease Amino acids BSA computational simulations Diabetes Drugs Fluorescence Glucose Hydrogen Ligands Metabolites Myriocin non-enzymatic glycation Proteins spectroscopic techniques |
SummonAdditionalLinks | – databaseName: DOAJ Directory of Open Access Journals dbid: DOA link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1La9wwEBYll_ZS-qRu06JCoVAwsa2XdUxC0rSQQKGB3ISexJDIIbt72P76ztjeZd1Ae-nR1siWRiPNQ9I3hHziwlc8SgsjkHTJWYhla5krtRSNcqqpZMCA_vmFPLvk36_E1U6qLzwTNsIDj4w7sDx660AOwZLhOogWTBaZVK2jDjawhKsv6LyNMzW5WjXopXEPk4FTf3A7ppqNC9x1lBqTSexooQGs_-GS_OcxyR29c_qMPJ0MRno4NvQ5eRTzC_L4eJOn7SX58S1fd67DzXI6YhEvaJ_o-fq-A8Zn2md60efyJP9aD_Cs9OvNeozTIdkRRhQihSVjdUuHeH2XX5HL05Ofx2fllCih9IKpZWlbaxubqlZzAZzW8OQkzM42csWcjcymNqo66CoxJxtbMy7qFBPmDErac_aa7OU-xzeEIr5gjFrCFwP3PLmQQkAQOSVSXXtVkGrDOOMnFHFMZnFjwJtAXpsHvC7Il22VuxFC42_ERzgaW0JEvx5egEyYSSbMv2SiIJ9xLA3OUWict9NVA-giol2ZQ8UFLDxg6RZkf0YJQ-fnxRtpMNPcXhhoKpipAn5ZkI_bYqyJ59Vy7FcDjRYNKv-CqJkUzXo2L8nd9YDvDU6lErx--z9Y8Y48afDCxnD8cJ_sLe9X8T2YUUv3YZgxvwECfB4d priority: 102 providerName: Directory of Open Access Journals |
Title | Inhibitory Effects of Myriocin on Non-Enzymatic Glycation of Bovine Serum Albumin |
URI | https://www.proquest.com/docview/2728515396 https://www.proquest.com/docview/2729520128 https://pubmed.ncbi.nlm.nih.gov/PMC9607541 https://doaj.org/article/a4ecab73099949d581396f719e9dad3f |
Volume | 27 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1La9wwEBZtcmgvpU_qNl1cKBQKJrYlWdapZMNu0kKWtjSwNyPrkRgSOd3HYfvrOyN7N3EDuRhsjWxrRjMajaRvCPnEuE6ZLRRIwMmEUWOTUtE6kQXPRS3ytDAY0D-bFafn7Pucz_uA27LfVrm1icFQm1ZjjPwwFzk4B5zK4uvNnwSzRuHqap9C4zHZR-gy7NVifjvhymB06lYyKUztD6-7hLN2iWuPhcSUEnfGogDZf98w_79Z8s7oM31OnvVuY3zUyfkFeWT9S_LkeJut7RX5-c1fNnWDS-Zxh0i8jFsXn20WDbDfx62PZ61PJv7vJoC0xidXmy5ah2RjjCvYGAzH-joOUfvGvybn08nv49OkT5eQaE7FKlGlUrlyaSkZB35LuKsL0NHSMkFrZalypRWZkamjdZGrjDKeOeswc5CTmtE3ZM-33r4lMaIMWisLeKNhmrnaOGMQSk5wl2VaRCTdMq7SPZY4prS4qmBOgbyu7vE6Il92VW46II2HiMcojR0hYmCHB-3ioupVqlLMalWDhQIfl0nDS3BmCycyaaVRhrqIfEZZVqip8HNa9QcOoImIeVUdCcbB_IC_G5GDASWITg-Lt72h6jV8Wd32x4h83BVjTdy15m27DjSS5-gCREQMetGgZcMS31wGlG-YWgrOsncPf_w9eZrjgYywvfCA7K0Wa_sB3KRVPQq6ANdyejIi--PJ7MevUQg5_AMalhjU |
linkProvider | ProQuest |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9QwELZKOZQLKi8RKGAkEBJS1CS24_iAUFu63aXdlZBaqbfgxHa7UuuUfahafhS_kZk8li6Veutx40k28Yxnxh77-wj5wEUZcZtq0IBTIWfGhplmRahSkchCJlFqcEF_OEr7J_z7qThdI3-6szC4rbLzibWjNlWJa-TbiUwgORBMpV-vfoXIGoXV1Y5CozGLQ7u4hinb9MvgG-j3Y5L09o_3-mHLKhCWgslZqDOtE-2iTHEBr6XgV5GCKWeWS1Zoy7TLrIyNihwr0kTHjIvYWYcEO06VnMFzH5CHnEEkx5PpvYPlBC-GaNhUTqEx2r5sCG7tFGudqUIKixuxr6YIuB0I_t-ceSPa9TbJ4zZNpTuNXT0ha9Y_JRt7HTvcM_Jj4M_HxRhL9LRBQJ7SytHhYjIGdXtaeTqqfLjvfy9qUFh6cLFoVgdRbBfXMSwFRzW_pHWVYOyfk5N76cgXZN1X3r4kFFENrVUpPNHwkrvCOGMQuk4KF8elDEjUdVxettjlSKFxkcMcBvs6v9XXAfm8vOWqAe64S3gXtbEURMzt-kI1OcvbIZxrbktdgEeEnJorIzJInlMnY2WV0Ya5gHxCXeboGeDlSt0ecIBPRIytfEdyAe4O8uuAbK1IgurK1ebOGvLWo0zzf_YfkPfLZrwTd8l5W81rGSUSTDkCIlesaOXLVlv8-LxGFYeprBQ8fnX3n78jG_3j4VF-NBgdviaPEjwMUm9t3CLrs8ncvoEUbVa8rccFJT_veyD-BQ9VUlU |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3db9MwELdGJwEviE8RGGAkEBJS1CS24_gBoXVrWRmrBmLS3jInsVmkzRn9ECp_Gn8dd_koK5P2tsfGlzTxffjOd_4dIW-4yANuYg0csMrnrDB-olnmq1hEMpNREBe4oX8wifeO-OdjcbxB_nRnYbCssrOJtaEuqhz3yPuRjMA5EEzFfduWRRzujj5e_PSxgxRmWrt2Go2I7JvlLwjfZh_Gu8Drt1E0Gn7f2fPbDgN-Lpic-zrROtI2SBQX8IoKfmUxiHViuGSZNkzbxMiwUIFlWRzpkHERWmOx2Y5VOWfw3FtkU2JU1CObg-Hk8Nsq3AthbWzyqIypoH_etLs1M8x8xgobWlxaCeuGAVeXhf9LNS-tfaP75F7rtNLtRsoekA3jHpI7O12vuEfk69idllmJCXva4CHPaGXpwXJaAvMdrRydVM4fut_LGiKWfjpbNnuFSDbAXQ1DwWwtzmmdMyjdY3J0I1P5hPRc5cxTQhHj0BgVwxMLnnObFbYoEMhOChuGufRI0E1cmrdI5thQ4yyFiAbnOr0y1x55v7rlooHxuI54gNxYESICd32hmv5IW4VONTe5zsA-gofNVSEScKVjK0NlVKELZj3yDnmZop2Al8t1e9wBPhERt9JtyQUYP_C2PbK1Rgmsy9eHO2lIW_syS_9pg0der4bxTqyZc6Za1DRKROiAeESuSdHal62PuPK0xhiHwFYKHj67_s9fkdughOmX8WT_Obkb4cmQus5xi_Tm04V5Af7aPHvZKgYlJzeti38BLNZX5w |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Inhibitory+Effects+of+Myriocin+on+Non-Enzymatic+Glycation+of+Bovine+Serum+Albumin&rft.jtitle=Molecules+%28Basel%2C+Switzerland%29&rft.au=He%2C+Libo&rft.au=Liu%2C+Yang&rft.au=Xu%2C+Junling&rft.au=Li%2C+Jingjing&rft.date=2022-10-01&rft.pub=MDPI+AG&rft.issn=1420-3049&rft.eissn=1420-3049&rft.volume=27&rft.issue=20&rft_id=info:doi/10.3390%2Fmolecules27206995&rft.externalDocID=A745963533 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1420-3049&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1420-3049&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1420-3049&client=summon |